前列腺癌根治性放疗后PSA复发的发生率与预后意义:一项基于人群的研究
采用Phoenix标准定义复发,10年复发风险为25%(95%CI 24-25%),复发后10年前列腺癌死亡风险为35%(95%CI 33-37%)。复发后死亡风险因Gleason评分和复发时间而异,部分结果与EAU复发风险分组不一致。
要点
- 根治性放疗后10年PSA复发风险25%,复发后10年前列腺癌死亡风险35%。
- 复发时间早且Gleason评分高者死亡风险显著更高(如18个月内复发、Gleason 9-10者达75%)。
- 部分风险估计与EAU复发风险分组分类不一致。
核心结论
- 根治性放疗后PSA复发后前列腺癌死亡风险因Gleason评分和复发时间不同而差异很大,部分估计与EAU复发风险分组不一致。
主要发现
- 10年复发风险为25%(95%CI 24-25%)。
- 复发后10年前列腺癌死亡风险为35%(95%CI 33-37%)。
- 复发时间>3年者,Gleason 6和3+4的10年死亡风险分别为18%和19%。
- 复发时间≤18个月者,Gleason 4+3和9-10的死亡风险分别为52%和75%。
- 放疗后1年复发者,Gleason 9-10较Gleason 6的死亡风险高四倍(86% vs 22%)。
关键数值与推荐
- 复发定义为PSA水平较最低点升高≥2 ng/mL(Phoenix标准)。
临床怎么用
- 对于放疗后PSA复发患者,应结合Gleason评分和复发时间进行个体化风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate risk of prostate-specific antigen (PSA) relapse after radical radiotherapy (RT) for prostate cancer (PCa), and risk of PCa death after relapse according to Gleason score and time to relapse. PATIENTS AND METHODS: Men in the National Prostate Cancer Register of Sweden who underwent primary radical RT in 2007-2024 were followed until 31 December 2024. Relapse was defined as a PSA level increase of ≥2 ng/mL above nadir (Phoenix criteria). Competing risk cumulative incidence analyses were used to estimate risk of PSA relapse and risk of PCa death after relapse according to Gleason score and time to relapse. RESULTS: The 10-year risk of relapse in 26 634 men treated with RT was 25% (95% confidence interval [CI] 24-25%). The 10-year risk of PCa death after relapse was 35% (95% CI 33-37%). In men with relapse after >3 years the risk was 18% for Gleason score 6 and 19% for Gleason score 3 + 4, while in men with a relapse within 18 months the risk was 52% for Gleason score 4 + 3 and 75% for Gleason score 9-10. In men with a relapse at 1 year after RT there was a four-fold higher risk of PCa death for men with Gleason score 9-10 compared to men with Gleason score 6 (86% vs 22%). In contrast, in men with a relapse at 10 years after RT there were little differences in risk of PCa death according to Gleason (14% vs 23%). CONCLUSION: In this population-based study of RT for PCa, there was a wide range in the estimates of risk of PCa death after relapse in highly granular groups according to Gleason score and time to relapse. Notably, some estimates did not align with the European Association of Urology relapse risk group classification.
引用
- Zaurito P, Garmo H, Gedeborg R, et al. Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study. BJU Int. 2026. PMID: 41537396. doi:10.1111/bju.70148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。